Breaking News, Collaborations & Alliances

Fujifilm Diosynth Biotechnologies, Istari Oncology Enter Manufacturing Agreement

To advance its viral immunotherapy PVSRIPO.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies (FDB) and Istari Oncology have entered into an agreement for the manufacturing of Istari Oncology’s viral immunotherapy, PVSRIPO, currently being investigated for the treatment of solid tumors.   Fujifilm Diosynth Biotechnologies is a contract development and manufacturing organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and viral gene therapies. Istari Oncology is a clinical-stage biotechnology company foc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters